TITLE

Atrial fibrillation in haemodialysis patients: Do the guidelines for anticoagulation apply?

AUTHOR(S)
Sisu, Roxana
PUB. DATE
September 2007
SOURCE
Maedica - a Journal of Clinical Medicine;2007, Vol. 2 Issue 3, p261
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study on the role of anticoagulation guidelines in the atrial fibrillation (AF) in haemodialysis patients. The risk of hemorrhage due to vessel and platelet abnormalities associated with abnormal platelet adhesion and aggregation mechanisms are very high in haemodialysis patients because of the use of anticoagulants during dialysis. It states that the study demonstrated the distorted risk benefit profile of anticoagulation for AF in the haemodialysis population and as a result, the strong evidence for anticoagulating patients with AF may not be safely extrapolated to the haemodialysis population. It is also suggested that clinicians should exercise caution and individualize the risk-benefit profile of anticoagulation for AF for each patient.
ACCESSION #
33777310

 

Related Articles

  • Relationships between Anticoagulation, Risk Scores and Adverse Outcomes in Dialysis Patients with Atrial Fibrillation. Wang, Tom Kai Ming; Sathananthan, Janarthanan; Marshall, Mark; Kerr, Andrew; Hood, Chris // Heart, Lung & Circulation;Mar2016, Vol. 25 Issue 3, p243 

    Background: Atrial fibrillation (AF) is the commonest cardiac arrhythmia including in end-stage renal failure patients, but controversy remains whether these patients benefit from anticoagulation. We reviewed the characteristics, management and outcomes of end-stage renal failure...

  • Coumarin use in dialysis patients with atrial fibrillation: yes, after individual risk stratification. Hörl, Walter H. // Nephrology Dialysis Transplantation;Dec2009, Vol. 24 Issue 12, p3902 

    A correction to the article "Coumarin Use in Dialysis Patients With Atrial Fibrillation: Yes, After Individual Risk Stratification" that was published in the November 2009 issue is presented.

  • Warfarin for stroke prevention in hemodialysis patients with non-valvular atrial fibrillation. Badr, Souzi; Cameron, Karen; Battistella, Marisa // CANNT Journal;Jul-Sep2015, Vol. 25 Issue 3, p22 

    The article discusses how the anticoagulant warfarin can be used to prevent strokes in hemodialysis patients with non-valvular atrial fibrillation (AF). It covers the pathophysiology of atrial fibrillation and concludes that warfarin's ability to reduce stroke rate is conflicting based on...

  • Infections Associated with Use of the LifeSite Hemodialysis Access System. Ross, John J.; Narayan, Geetha; Bergeron, Ellen K.; Worthington, Michael G.; Strom, James A. // Clinical Infectious Diseases;7/1/2002, Vol. 35 Issue 1, p93 

    We observed infection rates associated with the LifeSite Hemodialysis Access System, a novel dialysis device consisting of 2 subcutaneously implanted valves accessed by repeated use of fibrous tissue tracts, of 4.8 total infections and 8.1 first episodes per 1000 patient-days. These rates are...

  • Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation. Genovesi, Simonetta; Rossi, Emanuela; Gallieni, Maurizio; Stella, Andrea; Badiali, Fabio; Conte, Ferruccio; Pasquali, Sonia; Bertoli, Silvio; Ondei, Patrizia; Bonforte, Giuseppe; Pozzi, Claudio; Rebora, Paola; Valsecchi, Maria Grazia; Santoro, Antonio // Nephrology Dialysis Transplantation;Mar2015, Vol. 30 Issue 3, p491 

    …the issue of whether to anticoagulate or not is far from resolved and this prospective study by Genovesi et al. teaches us that although haemodialysis patients with atrial fibrillation treated with warfarin are at high risk of bleeding…the net clinical benefit of warfarin use in HD...

  • Prevention of Stroke by Antithrombotic Therapy in Patients with Atrial Fibrillation. Manolis, Athanasios J.; Poulimenos, Leonidas E. // JAFIB: Journal of Atrial Fibrillation;Feb/Mar2013, Vol. 5 Issue 5, p84 

    Atrial Fibrillation (AF) is the most common clinically significant sustained cardiac arrhythmia, a major risk factor for strokes whether it is symptomatic or silent. The older CHADS2 score and the newer CHA2DS2-VASc are well validated to determine stroke risk and guide initiation of...

  • Achieving target international normalization ratio in haemodialysis patients with atrial fibrillation: is it feasible? Tsagalis, Georgios; Gorguet, Henri; Labbé, Isabelle // NDT Plus;Aug2011 Supplement 4, Vol. 4 Issue 4, p279 

    No abstract available.

  • Caution Urged Regarding Warfarin Use.  // Renal & Urology News;Apr2011, Vol. 10 Issue 4, p17 

    The article suggests weighing the potential complications of warfarin therapy when used to treat atrial fibrillation (AF) in hemodialysis (HD) patients.

  • Incidence of AF increased in older patients initiating dialysis.  // Cardiology Today;Dec2012, Vol. 15 Issue 12, p33 

    The article discusses research done by B. A. Goldstein and colleagues which investigated the incidence of atrial fibrillation in a U.S. population of older patients initiating dialysis, published in a 2012 issue of "Circulation."

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics